Encouraging FDA report on Chiron factory
5th Sep 2005, 13:33 GMT
Chiron Corporation is thought to be a step closer to re-launching its flu vaccine back on the US market after US regulators acknowledged that changes made to its UK manufacturing plant were "generally acceptable".
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol